George Harrison Talbot, Director at Nabriva Therapeutics plc (NBRV), bought 14,500 shares at $2.75 ($40K) on 2018-07-31, disclosed to the SEC on 2018-08-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| NBRV | SELL | 2017-05-25 | $33K | — | Filing → |
| NBRV | SELL | 2017-05-17 | $21K | — | Filing → |